
Gynecologic Cancer Care: Prevention, Treatment & Surveillance
22 lessons · 2h 30m
Published: October 2026
This course examines gynecologic cancer care across the spectrum of surveillance, radiation therapy, and hereditary risk management. You will learn to apply current surveillance guidelines and evaluate the evidence supporting de-escalation of cytology and routine imaging, as well as to understand advances in radiation planning, brachytherapy techniques, and long-term toxicity management. The curriculum also covers the identification of hereditary cancer red flags, approaches to patient counseling for genetic testing and risk-reducing surgery, hormone therapy after gynecologic cancer, and the emerging applications of circulating tumor DNA (ctDNA). Additional topics include survivorship counseling to support quality of life after treatment. Learn from Drs. Ritu Salani, Andrew Lim, Mona Guo, and Marcia Ciccone as they share practical expertise and clinical strategies in gynecologic oncology.
Lessons
Surveillance after Gynecologic Cancer Treatment: Evidence & Practice
- 1Building Surveillance Guidelines from Limited Prospective Evidence
- 2Lead Time Bias and the Goals of Cancer Surveillance
- 3Ovarian Cancer Surveillance: Symptom Review, CA-125, and Physical Examination
- 4Endometrial Cancer Surveillance after the TOTEM Trial
- 5Cytology De-Escalation and Hormone Therapy after Gynecologic Cancer
- 6Circulating Tumor DNA: Applications, Limitations, and Evidence Gaps
- 7Practical ctDNA Use and Retiring Routine Surveillance Cytology
Radiation Therapy for Gynecologic Cancers: Techniques & Toxicity
- 8From Four-Field Box to IMRT: Modern Radiation Planning and Delivery
- 9Hypofractionation: Why Gynecologic Regimens Remain Longer Than Prostate
- 10Image-Guided Interstitial HDR Brachytherapy for Cervical Cancer
- 11Why Brachytherapy Cannot Be Replaced by External Beam Boost
- 12Cervical Cancer Survivorship: Hormone Therapy, Dilators, and Sexual Health
- 13Long-Term Radiation Toxicity: Mechanisms, Management, and Risk Factors
- 14Re-Irradiation, Palliative Regimens, and Stereotactic Radiosurgery for Brain Metastases
Hereditary Gynecologic Cancer Syndromes: Testing, Counseling & Risk Reduction
- 15Recognizing Hereditary Cancer Red Flags in the Family History
- 16Referral Criteria, Pretest Counseling, and Variants of Uncertain Significance
- 17Genetic Testing Logistics and Coordinating High-Risk Care
- 18Counseling the BRCA1 Carrier: Surgical Timing and Salpingectomy Trials
- 19Risk-Reducing Surgery Technique, Breast Screening, and Chemoprevention
- 20Elevated Risk without a Mutation: Thresholds and Screening Limits
- 21Nonhormonal Menopause Management and Lynch Syndrome Tumor Screening
- 22Germline Testing, Insurance Barriers, Fertility Referral, and Cascade Testing
Topics
- Brachytherapy
- Brain Metastasis
- BRCA Gene
- Breast Cancer
- Cervical Cancer
- Circulating Tumor DNA (ctDNA)
- Cytology
- Endometrial Cancer
- Genetic Counseling
- Genetic Testing
- Gynecologic Oncology
- Gynecology
- Lynch Syndrome
- Medical Oncology
- OBGYN
- Oophorectomy
- Ovarian Cancer
- Pelvic Exam
- Physical Therapy
- Radiation Oncology
- Radiation Therapy
- Reproductive Endocrinology and Infertility (REI)
- Salpingectomy
- Stereotactic Radiation
- Vaginal Stenosis
- Vulvar Cancer
- Women's Health

